￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

Afatinib is the first oral targeted drug for lung squamous cell carcinoma approved by the FDA_ Kanghule

2025-10-19 11:44:20

Check Details
The broad-spectrum anti-tumor drug larotrectinib is applicable to the population, usage and dosage

2025-10-19 11:44:20

Check Details
How effective is nivolumab in the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Afatinib can effectively improve the survival of patients with lung squamous cell carcinoma_ Kanghule

2025-10-19 11:44:20

Check Details
How long can one live after gefitinib is used to treat non-small cell lung cancer?

2025-10-19 11:44:20

Check Details
Can nivolumab alone be used to treat lung cancer

2025-10-19 11:44:20

Check Details
How long does it take to develop resistance to the anti-cancer drug larotrectinib?

2025-10-19 11:44:20

Check Details
Median survival time of cabozantinib in lung cancer treatment

2025-10-19 11:44:20

Check Details
Will the NTRK-targeted drug larotinib be launched in China?

2025-10-19 11:44:20

Check Details
What is lung cancer? What are the treatments for lung cancer

2025-10-19 11:44:20

Check Details
Can gefitinib be used to treat early-stage lung cancer?

2025-10-19 11:44:20

Check Details
Usage and dosage of the anticancer drug cabozantinib in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识